[Comment on the study by H.G. Schneider et al.: "B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea"].
Krause
M
M
Medizinische Klinik, Kantonsspital Münsterlingen. martin.krause@stgag.ch
D003362:Cost-Benefit Analysis; D003937:Diagnosis, Differential; D004417:Dyspnea / Q000097:blood / Q000209:etiology*; D004636:Emergency Service, Hospital / Q000191:economics*; D006333:Heart Failure / Q000097:blood / Q000175:diagnosis*; D006801:Humans; D007388:Internal Medicine / Q000191:economics; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D011237:Predictive Value of Tests; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic
D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain